177lu-psma-617
Showing 1 - 11 of 11
Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco
Not yet recruiting
- Castrate Resistant Prostate Cancer
- +3 more
- Pembrolizumab
- 177Lu-PSMA-617
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 1, 2023
Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (177Lu-PSMA-617, PSMA-11)
No longer available
- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- 177Lu-PSMA-617
- PSMA-11
- (no location specified)
Jan 12, 2023
Prostate Cancer Trial in New York (177Lu-PSMA-617, Stereotactic Body Radiotherapy (SBRT))
Active, not recruiting
- Prostate Cancer
- 177Lu-PSMA-617
- Stereotactic Body Radiotherapy (SBRT)
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Nov 17, 2022
Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Melbourne (Cabazitaxel, 177Lu-PSMA-617)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- mCRPC
- Cabazitaxel
- 177Lu-PSMA-617
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Jul 20, 2022
Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)
Recruiting
- Metastatic Hormone Naive Prostate Cancer
- 177Lu-PSMA-617
- Docetaxel
-
Sydney, New South Wales, Australia
- +4 more
Nov 4, 2022
Prostate Cancer Trial in New Orleans, New York (177Lu-PSMA-617, 68Ga-PSMA-HBED-CC)
Active, not recruiting
- Prostate Cancer
- 177Lu-PSMA-617
- 68Ga-PSMA-HBED-CC
-
New Orleans, Louisiana
- +1 more
Nov 20, 2021
Prostate Cancer Trial in New York (177Lu-PSMA-617, 177Lu-J591, 68Ga-PSMA-HBED-CC)
Terminated
- Prostate Cancer
- 177Lu-PSMA-617
- +2 more
-
New York, New YorkWeill Cornell Medical College
Jul 29, 2021
Prostate Cancer Trial in Vancouver, Montreal, Quebec City (177Lu-PSMA-617, Docetaxel)
Suspended
- Prostate Cancer
- 177Lu-PSMA-617
- Docetaxel
-
Vancouver, British Columbia, Canada
- +3 more
Jun 13, 2022
Prostate Cancer Trial in Amsterdam, Groningen, Nijmegen (177Lu-PSMA-617)
Recruiting
- Prostate Cancer
- 177Lu-PSMA-617
-
Amsterdam, Netherlands
- +3 more
Oct 17, 2021
Prostatic Tumor Trial in Amsterdam, Utrecht (177Lu-PSMA-617, EBRT)
Recruiting
- Prostatic Neoplasm
- 177Lu-PSMA-617
- EBRT
-
Amsterdam, Netherlands
- +1 more
Dec 21, 2021
Metastatic Castration Resistant Prostate Cancer Trial in Los Angeles, Houston (177Lu-PSMA-617)
Terminated
- Metastatic Castration Resistant Prostate Cancer
- 177Lu-PSMA-617
-
Los Angeles, California
- +1 more
Mar 1, 2021